Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 24, 2013John Paolucci Joins Aratana as Director of Marketing
Aratana Therapeutics (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it has...
-
Oct 21, 2013
Aratana Therapeutics, Inc. (Nasdaq: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it has...
-
Oct 15, 2013The Mayor's Alliance for NYC's Animals and Adoptable Pets to Join Aratana on NASDAQ Stage
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets (pet...
-
Oct 14, 2013Adds Biologics to its Pet Therapeutics Platform
Aratana Therapeutics, Inc. (Nasdaq: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of...
-
Oct 1, 2013
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets (pet...
-
Sep 27, 2013Presentation Scheduled for Friday, September 27 at 10:30 a.m. ET
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets (pet...
-
Sep 5, 2013
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets (pet...
-
Sep 3, 2013Presentation and Award Sponsorship Showcase Aratana's Vision and Pursuit of Innovation
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets (pet...
-
Aug 29, 2013To Be Held September 11, 2013, 6:00 p.m. Eastern Time
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and...
-
Aug 12, 2013Announces Expansion of Pet Therapeutics Pipeline
Aratana Therapeutics, Inc. (NASDAQ: PETX) today announced its financial results for the second quarter of 2013, product development...